{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:26:37Z","timestamp":1793607997681,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129112","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:40:00Z","timestamp":1788522000000},"page":"129112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Integrating life-course immunization within harm-reduction outreach for key populations in India: Operationalizing the YUVA framework"],"prefix":"10.1016","volume":"92","author":[{"given":"Laxit K.","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129112_bb0005","doi-asserted-by":"crossref","first-page":"738","DOI":"10.25259\/IJMR_2821_2025","article-title":"Young adult immunization initiative (YUVA\/YAII): a policy framework for India\u2019s life-course vaccination strategy","volume":"162","author":"Bhatt","year":"2026","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2026.129112_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0004475","article-title":"Programmatic mapping and population size estimation of key population in India: method and findings","volume":"5","author":"Kumar","year":"2025","journal-title":"PLOS Global Public Health"},{"key":"10.1016\/j.vaccine.2026.129112_bb0015","series-title":"Magnitude of substance use in India. New Delhi","author":"Ambekar","year":"2019"},{"key":"10.1016\/j.vaccine.2026.129112_bb0020","first-page":"59","article-title":"Need for shifting responsibility for adult hepatitis B vaccination from the patient to the healthcare provider","volume":"3","author":"Kaushal","year":"2026","journal-title":"Preventive Medicine: Research & Reviews"},{"key":"10.1016\/j.vaccine.2026.129112_bb0025","series-title":"National AIDS and STD control Programme phase-V (2021\u20132026). New Delhi","author":"MoHFW GoI N","year":"2022"},{"key":"10.1016\/j.vaccine.2026.129112_bb0030","doi-asserted-by":"crossref","unstructured":"Bhatt LK. Anti-drug vaccines as a harm reduction strategy: potential, limitations, and translational challenges. Bulletin of the National Research Centre 2025 49:1 2025;49:42-. doi:https:\/\/doi.org\/10.1186\/S42269-025-01336-0.","DOI":"10.1186\/s42269-025-01336-0"},{"key":"10.1016\/j.vaccine.2026.129112_bb0035","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-14-820","article-title":"Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities","volume":"14","author":"Bowman","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2026.129112_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-019-3926-2","article-title":"Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study","volume":"19","author":"Taylor","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129112_bb0045","doi-asserted-by":"crossref","unstructured":"Yee NS, Naing AY, Cuesta JG, Das M, Dave K. Gaps in hepatitis B vaccination completion and sero-protection for people who inject drugs in Hpakant, Myanmar, 2015-2018. Trop Med Infect Dis 2020;5. doi:https:\/\/doi.org\/10.3390\/TROPICALMED5020077.","DOI":"10.3390\/tropicalmed5020077"},{"key":"10.1016\/j.vaccine.2026.129112_bb0050","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4103\/ijmr.ijmr_1930_23","article-title":"HIV, hepatitis B & C in people who inject drugs in India: a systematic review of regional heterogeneity & overview of opioid substitution treatment","volume":"158","author":"Shukla","year":"2024","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2026.129112_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-025-22623-5","article-title":"Low hepatitis B vaccination coverage in New Delhi, India: urgent call for universal adult hepatitis B vaccination","volume":"25","author":"Kaushal","year":"2025","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2026.129112_bb0060","article-title":"Prevalence of human papilloma virus infection and risk of cervical intraepithelial neoplasia among female sex workers in Mumbai, India","volume":"18","author":"Pahwa","year":"2024","journal-title":"Ecancermedscience"},{"key":"10.1016\/j.vaccine.2026.129112_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12091079","article-title":"Mpox outbreak 2022: a comparative analysis of the characteristics of individuals receiving MVA-BN vaccination and people diagnosed with Mpox infection in Milan, Italy","volume":"12","author":"Passini","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2026.129112_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijregi.2026.100917","article-title":"Community-based sentinel surveillance for Mpox-like disease among men who have sex with men and transgender individuals in India: a cross-sectional study","volume":"20","author":"Sahay","year":"2026","journal-title":"IJID Regions"},{"key":"10.1016\/j.vaccine.2026.129112_bb0075","article-title":"SC 582; (2008) 1 SCC 234","volume":"2022","author":"Jacob Puliyel vs. Union of India and Ors. AIR","year":"2008","journal-title":"Civil Appeal, Supreme Court of India"},{"key":"10.1016\/j.vaccine.2026.129112_bb0080","unstructured":"Justice K.S. Puttaswamy (Retd) vs Union of India. AIR 2018 SC (Supp) 1841; 2019 (1) SCC 1. Supreme Court of India. n.d. https:\/\/indiankanoon.org\/doc\/127517806\/ (accessed December 30, 2025)."},{"key":"10.1016\/j.vaccine.2026.129112_bb0085","author":"National Legal Services Authority vs. Union of India"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:34:08Z","timestamp":1793604848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26009217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":17,"alternative-id":["S0264410X26009217"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129112","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating life-course immunization within harm-reduction outreach for key populations in India: Operationalizing the YUVA framework","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129112"}}